Market Intelligence

JDcom Inc JD Positioned to Benefit from Broad Global Retail Sector Momentum Amid Robust March Sales Growth EXLS ExlService Holdings reports Q4 2025 EPS beat and 136 percent year over year revenue growth shares dip modestly Marathon Petroleum MPC Outperforms Broad Market Ahead of Q1 2026 Earnings Release Why Loma Negra LOMA Stock Could Rise Eye on Rally 20260422 Why RiverNorth RMM could be the anchor your portfolio needs 062 20260511 SPRU Spruce posts negative 038 Q4 2025 EPS stock dips 03 percent with no analyst estimates for comparison Why Fomento FMX business model holds up in any market Eye on Rally 20260503 Is APi Group APG building a durable competitive moat In Focus 20260506 TILE Interface delivers 191 percent Q4 2025 EPS beat even as shares dip 018 percent lower today AIxCrypto AIXC Slips 201 Testing 116 Support 20260519 Analysts Bullish on Ether Accumulator as Corporate Crypto Treasury Strategies Gain Traction Ares Mgmt ARES Slides 209 as Selling Pressure Mounts 20260519 Amrize AMRZ Q1 2026 Earnings Miss by Significant Key Takeaways JPMorgan Curates Summer Reading List for Wealthy Clients AI Leadership and Lemons Among Themes BGSI Q1 2026 Earnings EPS Misses Estimates Amid Narrow Beat Danaher DHR Delivers Q1 2026 Beat EPS 206 vs 196 Expected Entergy Corporation ETR Q1 2026 Earnings Fall Short EPS 086 Misses Mark Fed Chair Powell Vows Not to Be Shadow Chair as Historic Overlap with Incoming Chair Warsh Approaches Salesforce Shares Decline on Soft Revenue Outlook Amid Persistent AI Disruption Concerns Toronto Blue Jays Manager Reacts Strongly to Key Player Acquisition from San Francisco Giants MENA Leaders Advocate for Holistic Housing Policy Beyond Construction at Baku Forum Indian Bond Bull Market May Pause but Still Has Room to Run Analyst Suggests US Productivity Growth Cools in Q4 as Labor Costs Rise Stirring Inflation Concerns SAM Q1 2026 Earnings EPS Misses Estimates Amidst Persistent Cost Headwinds Utah Medical Products Inc UTMD Q1 2024 Earnings EPS of 109 Reported Stock Gains Modestly Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending Income Opportunity Realty Investors Inc IOR Q4 2024 Earnings Positive EPS Marks Quarter Stock Slightly Declines MUSA Q1 2026 Earnings Massive EPS Beat Defies Light Revenue Disclosure Stock Slips Dillards Capital Trust I DDT Holds Steady Near Key Support Levels Anixa Biosciences ANIX Holds Steady at 273 as Consolidation Continues Schneider National SNDR Surges Over 37 Key Support and Resistance Levels in Focus Live Oak Bancshares LOB Slips Fractionally Amid Consolidation Near Support